Peroral Levosimendan in Chronic Heart Failure

Clinical trial NCT00130884 · COMPLETED

Trial details

NCT number: NCT00130884
Sponsor: Orion Corporation, Orion Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Heart Failure Heart Diseases

Start date: 2005-03-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.